High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study
- Citation:
- Blood vol 111 (11) 5371-5379
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- 606
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- CA101140, U10 CA077658, CA098933, CA016058, CA089341, R01 CA089341, CA077658, U24 CA114725, U10 CA101140, R01 CA098933, K01 CA096887, P30 CA016058, CA114725, CA096887
- Corr. Author:
- Authors:
- Christian Langer Michael D. Radmacher Amy S. Ruppert Susan P. Whitman Peter Paschka Krzysztof Mrózek Claudia D. Baldus Tamara Vukosavljevic Chang-Gong Liu Mary E. Ross Bayard L. Powell Albert de la Chapelle Jonathan E. Kolitz Richard A. Larson Guido Marcucci Clara D. Bloomfield
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-19808, CALGB-20502, CALGB-8461, CALGB-9621, CALGB-9665
- Phases:
- 1, 3, N/A
- Keywords:
- Neoplasia